Simon has over six years of professional trading experience across FX, commodities and equities. He has a strong passion for financial markets and is particularly focused on price action trading
Shares of Beximco Pharmaceuticals (LON: BXP) today surged 48.2% after the company announced an exclusive deal with the Serum Institute of India to be the sole supplier of the COVID-19 vaccine in Bangladesh.
The deal will see Beximco contribute funds to facilitate the vaccine’s development, which will be adjusted according to the vaccine’s final pricing.
The Serum Institute has partnered with AstraZeneca, the Gates Foundation and Gavi to produce over a billion vaccines for global distribution.
Beximco clarified that the vaccines supplied to Bangladesh will be on a priority basis and that its investment will depend on regulatory approvals, SII’s production capacity and its earlier commitments to other countries.
BXP share price
BXP shares today surged 48.2% to trade at 81.5p having ended yesterday’s session trading at 55.0p.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 75 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .